112 related articles for article (PubMed ID: 16328028)
41. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
[TBL] [Abstract][Full Text] [Related]
42. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
Sievers EM; Bart RD; Backhus LM; Lin Y; Starnes M; Castanos R; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1242-9. PubMed ID: 15942563
[TBL] [Abstract][Full Text] [Related]
44. Combination of the multipotent mesenchymal stromal cell transplantation with administration of temozolomide increases survival of rats with experimental glioblastoma.
Bryukhovetskiy I; Bryukhovetsky A; Khotimchenko Y; Mischenko P; Tolok E; Khotimchenko R
Mol Med Rep; 2015 Aug; 12(2):2828-34. PubMed ID: 25955107
[TBL] [Abstract][Full Text] [Related]
45. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
[TBL] [Abstract][Full Text] [Related]
46. Up-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesis.
Piplani H; Vaish V; Rana C; Sanyal SN
Mol Carcinog; 2013 Nov; 52(11):845-58. PubMed ID: 22623379
[TBL] [Abstract][Full Text] [Related]
47. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
48. Potentiation of antiglioma effect with combined temozolomide and interferon-beta.
Park JA; Joe YA; Kim TG; Hong YK
Oncol Rep; 2006 Dec; 16(6):1253-60. PubMed ID: 17089046
[TBL] [Abstract][Full Text] [Related]
49. Avoiding glucocorticoid administration in a neurooncological case.
Rutz HP; Hofer S; Peghini PE; Gutteck-Amsler U; Rentsch K; Meier-Abt PJ; Meier UR; Bernays RL
Cancer Biol Ther; 2005 Nov; 4(11):1186-9. PubMed ID: 16258258
[TBL] [Abstract][Full Text] [Related]
50. Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
Reardon DA; Quinn JA; Vredenburgh J; Rich JN; Gururangan S; Badruddoja M; Herndon JE; Dowell JM; Friedman AH; Friedman HS
Cancer; 2005 Jan; 103(2):329-38. PubMed ID: 15558802
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
Kisková T; Jendželovský R; Rentsen E; Maier-Salamon A; Kokošová N; Papčová Z; Mikeš J; Orendáš P; Bojková B; Kubatka P; Svoboda M; Kajo K; Fedoročko P; Jäger W; Ekmekcioglu C; Kassayová M; Thalhammer T
Eur J Cancer Prev; 2014 Nov; 23(6):506-13. PubMed ID: 25254309
[TBL] [Abstract][Full Text] [Related]
52. Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model.
Sandström M; Johansson M; Bergström P; Bergenheim AT; Henriksson R
J Neurooncol; 2008 May; 88(1):1-9. PubMed ID: 18228115
[TBL] [Abstract][Full Text] [Related]
53. Current chemotherapy for glioblastoma.
Parney IF; Chang SM
Cancer J; 2003; 9(3):149-56. PubMed ID: 12952300
[TBL] [Abstract][Full Text] [Related]
54. Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.
Kosaka A; Ohkuri T; Okada H
Cancer Immunol Immunother; 2014 Aug; 63(8):847-57. PubMed ID: 24878890
[TBL] [Abstract][Full Text] [Related]
55. Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide.
Johansson AS; Pawelzik SC; Larefalk A; Jakobsson PJ; Holmberg D; Lindskog M
Leuk Lymphoma; 2009 Jul; 50(7):1198-203. PubMed ID: 19557641
[TBL] [Abstract][Full Text] [Related]
56. Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.
Kang GS; Wang XD; Mohler ML; Kirichenko OV; Patil R; Orr WE; Miller DD; Geisert EE
Anticancer Drugs; 2008 Oct; 19(9):859-70. PubMed ID: 18766000
[TBL] [Abstract][Full Text] [Related]
57. Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine.
Yerokun T; Winfield LL
Anticancer Res; 2015 Dec; 35(12):6419-24. PubMed ID: 26637851
[TBL] [Abstract][Full Text] [Related]
58. Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).
Paprottka PM; Roßpunt S; Ingrisch M; Cyran CC; Nikolaou K; Reiser MF; Mack B; Gires O; Clevert DA; Zengel P
BMC Cancer; 2015 May; 15():373. PubMed ID: 25947947
[TBL] [Abstract][Full Text] [Related]
59. [Caspase-independent programmed cell death induced by temozolomide in rat glioma C6 cell line].
Liu L; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):229-33. PubMed ID: 25736118
[TBL] [Abstract][Full Text] [Related]
60. Could the combination of celecoxib and 4HPR be an effective lung cancer treatment?
Cherukuri DP; Nelson MA
Cancer Biol Ther; 2005 Aug; 4(8):899-900. PubMed ID: 16222124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
